文献速递主动脉疾病

前瞻性随机预试验:复杂血管腔内胸腹主动脉瘤修复术中预防性与治疗性脑脊液引流比较

Prospective randomized pilot trial comparing prophylactic and therapeutic cerebrospinal fluid drainage during complex endovascular thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2024-04-06

该前瞻性多中心随机预试验在阿拉巴马大学伯明翰分校和马萨诸塞大学开展,20例接受分支/开窗血管腔内主动脉修复术(FBEVAR)的广泛胸腹主动脉瘤及弓部主动脉瘤患者随机分为预防性引流组(n=10)与治疗性引流组(n=10),主要结局为随机化可行性及共享腰大池引流方案依从性。结果显示两组方案依从性均为100%,预防性引流组1例(1/10;10%)发生腰大池置管相关不良事件(硬膜外血肿需椎板切除术,无神经功能缺损),共1例脊髓缺血(1/20;5%)发生于预防性引流组术后第9天继发于消化道出血相关低血压后。

要点

  • 预防性引流组与治疗性引流组各10例,随机化成功且无交叉。
  • 两组脊髓缺血预防方案依从性均为100%。
  • 预防性引流组发生1例腰大池置管相关硬膜外血肿需椎板切除术(1/10;10%)。

核心结论

  • 预防性腰大池引流在血管腔内胸腹主动脉瘤修复术中预防脊髓缺血的作用仍是研究课题,当前许多实践基于专家意见和经验而非严谨科学数据。
  • 本研究证明开展多中心随机临床试验以评估预防性与治疗性腰大池引流在血管腔内胸腹主动脉瘤修复术中预防脊髓缺血作用是可行的。

研究设计与样本

  • 前瞻性多中心随机预试验,在阿拉巴马大学伯明翰分校和马萨诸塞大学开展。
  • 共纳入20例因广泛胸腹主动脉瘤及弓部主动脉瘤接受FBEVAR的患者,随机分为预防性引流组(n=10)与治疗性引流组(n=10)。
  • 该预试验为可行性研究,未以检测临床结局的统计学差异为效能目标。
  • 主要结局为随机化可行性及对共享腰大池引流方案的依从性,次要结局包括引流管并发症发生率和脊髓缺血。

主要发现

  • 20例患者均成功随机化且无交叉,对照组(n=10)无预防性引流,实验组(n=10)接受预防性引流。
  • 两组年龄、合并症或既往主动脉手术史无差异;所有患者均接受FBEVAR治疗。
  • 动脉瘤分型为:I型10%、II型50%、III型35%、IV型5%;主动脉覆盖平均长度207 ± 21.6 mm,两组间主动脉覆盖长度、手术时间及失血量均无差异。
  • 两组脊髓缺血预防方案依从性均为100%。
  • 预防性引流组1例(n=1/10;10%)发生腰大池置管相关不良事件,表现为硬膜外血肿需椎板切除术,无神经功能缺损。

关键数值与推荐

  • 预防性引流组腰大池置管相关不良事件(硬膜外血肿需椎板切除术,无神经功能缺损)发生率为1/10(10%)。
  • 总体脊髓缺血发生率为1/20(5%),发生于预防性引流组术后第9天继发于消化道出血相关低血压后。
  • 两组对脊髓缺血预防方案的依从性均为100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该研究为预试验,未以检测临床结局的统计学差异为效能目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular techniques have transformed the management of thoracoabdominal aortic aneurysms (TAAAs). However, spinal cord ischemia (SCI) remains a prevalent and devastating complication. Prophylactic drainage of cerebrospinal fluid (CSF) is among the proposed strategies for prevention of SCI. Although prophylactic CSF drainage is widely used and conceptually attractive, prophylactic CSF drains have not been demonstrated to definitively prevent the occurrence nor mitigate the severity of SCI in endovascular TAAA repair. Whether or not outcomes of prophylactic drains are superior to therapeutic drains remains unknown. This pilot study was performed to determine the feasibility of a randomized clinical trial designed to investigate the role of prophylactic vs therapeutic CSF drains in the prevention of SCI in patients undergoing endovascular TAAA repair using branched and fenestrated endovascular aortic repair (FBEVAR). METHODS: This was a prospective multicenter randomized pilot clinical trial conducted at The University of Alabama at Birmingham and The University of Massachusetts. Twenty patients were enrolled and randomized to either the prophylactic drainage or therapeutic drainage groups, prior to undergoing FBEVAR for extensive TAAAs and arch aortic aneurysms. This was a pilot feasibility study that was not powered to detect statistical differences in clinical outcomes. The primary outcome was feasibility of randomization and compliance with a shared lumbar drain protocol. Secondary outcomes included rate of drain complications and SCI. RESULTS: Twenty patients were enrolled and successfully randomized, without any crossovers, to either the control cohort (n = 10), without prophylactic drains, or the experimental cohort (n = 10), with prophylactic drains. There were no differences in age, comorbidities, or history of prior aortic surgery across the cohorts. All patients were treated with FBEVAR. Aneurysm classifications were as follows: Extent I (10%), Extent II (50%), Extent III (35%), and Extent IV (5%). The average length of aortic coverage was 207 ± 21.6 mm. The length of aortic coverage did not vary across cohorts, nor did procedural times or blood loss volume. Compliance with the SCI prevention protocol was 100% across both groups. Within the prophylactic drain cohort, one patient experienced an adverse event related to lumbar drain placement, manifested as an epidural hematoma requiring laminectomy, without neurologic deficit (n = 1/10; 10%). There was one SCI event (n = 1/20; 5%), which occurred in the prophylactic drain cohort on postoperative day 9 following an episode of hypotension related to a gastrointestinal bleed. CONCLUSIONS: The role of prophylactic CSF drains for the prevention of SCI following endovascular TAAA repair is a topic of ongoing research, with many current practices based on expert opinion and experience, rather than rigorous scientific data. This study demonstrates the feasibility of a multicenter randomized clinical trial to evaluate the role of prophylactic vs therapeutic CSF drains in the prevention of SCI in patients undergoing endovascular TAAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Blakeslee-Carter J, Novak Z, Jansen JO, et al. Prospective randomized pilot trial comparing prophylactic and therapeutic cerebrospinal fluid drainage during complex endovascular thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2024. PMID: 38614137. doi:10.1016/j.jvs.2024.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。